PER 1.23% 8.0¢ percheron therapeutics limited

600%, page-35

  1. 13,117 Posts.
    lightbulb Created with Sketch. 1370


    Akki: you should be ashamed of yourself....frightening people with FAKE NEWS.....Anp are the leaders in Inflammation DMD which is the majority of DMD suffers.
    Atl 1102 is in Phase 2 re clinical trial on DMD....

    Sarepta and Duke UNi are not even in phase 1...only at PROOF of concept.... still many years

    http://investorrelations.sarepta.co...ics-signs-exclusive-global-collaboration-duke

    Shame on you Akki.”although early”
    Last edited by itsagas: 18/01/18
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.